Saxagliptin: a new dipeptidyl peptidase-Ⅳ inhibitor for the treatment of type 2 diabetesTAN Ling, XIA Lu-feng, SUN Chun-hua1099-1102
Cut the institutional costs should be the key to solve the problem of virtual-high medicine priceSONG Rui-lin, ZHANG Zheng-guang, DING Shu-juan1103-1107
Inspirations of the regulatory policies on post-marketed health products in Singapore to ChinaCHEN Lei, LIU Meng, ZHANG Lu, HUANG Qin1108-1111
Analysis for unapproved reasons of new Chinese herbal drug registrations in recent yearsZHU Fei-peng, HAN Wei1112-1115
Application of molecular imaging technology in drug developmentXIA Zhen-na, CHE Ai-ping, WANG Jie, YUAN Bo-jun, MAO Yu, LU Guo-cai1116-1120
Isolation and identification of major impurities during synthesis of the andrographolide derivative AL-1WANG Ding-yuan, WANG Zhong-li, WANG Yu-qiang, YU Pei1121-1123
Application of dexmedetomidine in the anesthetic management of functional neurosurgical proceduresXU Ting, LI Min1128-1130,1148
Progress in drug therapies for infections with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococciYUE Yang, DONG Yu-ying, YU Zhi-ying1131-1136,1152
Comparison of converting efficacy and safety of intravenous ibutilide and propafenone in Chinese patients with atrial fibrillation and atrial flutterWU Ying, JIANG Wen, YAN Xiao-wei, Hu Da-yi, LIU Xiao-hui, JIA San-qing, FAN Wei-hu, CAI Nai-sheng, WU Zong-gui, CHEN Jun-zhu, SHAN Jiang, HE Zhen-shan, LI Guang-ping, LI Yi-shi1137-1141